VLA-4 mediates both cell–cell and cell–matrix interactions in CLL-involved tissues by respectively binding to its ligands vascular cell adhesion molecule 1 (VCAM-1) and fibronectin (Ruoslahti, 1991; Hartmann et al., 2009). Here, FN1 is linked to B-cell chronic lymphocytic leukemia.